Sofwave Medical Ltd (SOFW) - Total Liabilities
Based on the latest financial reports, Sofwave Medical Ltd (SOFW) has total liabilities worth ILA22.97 Million ILA (≈ $61.57K USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore cash flow conversion of Sofwave Medical Ltd to assess how effectively this company generates cash.
Sofwave Medical Ltd - Total Liabilities Trend (2018–2025)
This chart illustrates how Sofwave Medical Ltd's total liabilities have evolved over time, based on quarterly financial data. Check SOFW cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Sofwave Medical Ltd Competitors by Total Liabilities
The table below lists competitors of Sofwave Medical Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Cogobuy Group
F:7C3
|
Germany | €6.18 Billion |
|
HCM II Acquisition Corp
NASDAQ:HOND
|
USA | $15.00 Million |
|
Banco Santander Brasil SA
BA:BSBR
|
Argentina | AR$1.17 Trillion |
|
Guangdong Anjubao Digital Tech
SHE:300155
|
China | CN¥138.36 Million |
|
Shanghai Menon Animal Nutrition Technology Co. Ltd.
SHE:301156
|
China | CN¥57.42 Million |
|
Holcim Argentina SA
BA:HARG
|
Argentina | AR$399.52 Billion |
|
Zhejiang Shengda Pharm
SHG:603079
|
China | CN¥561.97 Million |
|
Dongnan Electronics Co. Ltd. A
SHE:301359
|
China | CN¥93.98 Million |
Liability Composition Analysis (2018–2025)
This chart breaks down Sofwave Medical Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Sofwave Medical Ltd market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.43 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.65 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.39 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Sofwave Medical Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Sofwave Medical Ltd (2018–2025)
The table below shows the annual total liabilities of Sofwave Medical Ltd from 2018 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | ILA23.06 Million ≈ $61.84K |
+24.65% |
| 2024-12-31 | ILA18.50 Million ≈ $49.61K |
+7.62% |
| 2023-12-31 | ILA17.19 Million ≈ $46.09K |
+25.15% |
| 2022-12-31 | ILA13.74 Million ≈ $36.83K |
-2.34% |
| 2021-12-31 | ILA14.07 Million ≈ $37.71K |
+327.96% |
| 2020-12-31 | ILA3.29 Million ≈ $8.81K |
+55.41% |
| 2019-12-31 | ILA2.12 Million ≈ $5.67K |
+73.79% |
| 2018-12-31 | ILA1.22 Million ≈ $3.26K |
-- |
About Sofwave Medical Ltd
SofWave Medical Ltd. engages in the development, production, marketing, and distribution of non-invasive medical technology for skin firming and rejuvenation, tissue renewal, treatment of muscle, aging, and other physiological change in Israel, the United States, Europe, Southeast Asia, the Middle East, and internationally. The company offers an ultrasound technology that induces coagulation and … Read more